Role of endothelial dysfunction and circadian blood pressure profile disturbances in the development of cerebrovascular insufficiency among patients with metabolic syndrome by Yu. B. Lishmanov, N. Yu. Efimova, V. I. Chernov, I. Yu. Efimova, T. P. Kalashnikova

“…In MS patients, one of the pathogenetic mechanisms of cognitive dysfunction is a reduction in rCBF, which is linked to endothelial dysfunction and circadian BP profile disturbances.…”
Get full text

Steps to construct educational interventions on sexual dysfunction for healthcare professionals and patients. Experiences from the SECRET research study-group by Rikke Meyer, Sita R. Kotnis, Cecilie M.Ø. Fog-Petersen, Lise Tarnow, Annamaria Giraldi, Gesche Jürgens, Charlotte B. Jacobsen

“…Based on a content analysis of this material, a draft of the intervention was developed. …”
Get full text

TRIMETAZIDINE INFLUENCE ON FILTRATION AND TUBULOINTERSTITIAL FUNCTION OF KIDNEYS IN ISCHEMIC HEART DISEASE PATIENTS WITH CHRONIC HEART FAILURE AND RENAL DYSFUNCTION by N. A. Koziolova, I. I. Kolegova, M. V. Surovtseva

Get full text

Electrocardiographic signs of impaired depolarization (fragmented QRS, early ventricular repolarization, etc.) as markers of left ventricular systolic dysfunction by M. S. Gordeeva, I. A. Serdiukova, A. S. Krasichkov, E. V. Parmon

“…There was also no relationship between VAs and LV systolic dysfunction.…”
Get full text

Associations of genetic markers of the sympathoadrenal system and endothelial dysfunction with coronary heart disease on the example of a small Shoriya population by E. V. Mikhalina, T. A. Mulerova, V. N. Maksimov, M. I. Voevoda, M. Yu. Ogarkov

Get full text

Maternal gestational hypertension, smoking and pre‐eclampsia are associated with metabolic dysfunction‐associated fatty liver disease in overweight offspring by Hanna deRuyter, Linnea Aitokari, Siiri Lahti, Hanna Riekki, Heini Huhtala, Timo Lakka, Hannele Laivuori, Kalle Kurppa

“…Abstract Introduction Due to a steep increase in obesity, metabolic dysfunction‐associated fatty liver disease (MAFLD) has also become the most common chronic hepatic condition among children and adolescents. …”
Get full text

Fibrosis biomarkers and global myocardial strain in the diagnosis and prediction of diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction by A. V. Osokina, V. N. Karetnikova, S. N. Ryzhenkova, O. M. Polikutina, A. V. Ivanova, O. V. Gruzdeva, O. L. Barbarash

“…During the hospitalization, signs of diastolic dysfunction (DD) were detected in 5 (16,6%) patients; after 1 year, their number increased by 7 (23,3%). …”
Get full text

Dynamics of laboratory markers of endothelial dysfunction in patients with psoriatic arthritis under the influence of the interleukin-17A inhibitor netakimab by A. V. Petrov, O. A. Pritulo, A. A. Petrov

“…Objective: a comparative evaluation of the effect of the interleukin-17A inhibitor (iIL) netakimab (NTK) and methotrexate (MTX) on laboratory markers of endothelial dysfunction in patients with psoriatic arthritis (PsA) in comparison with the dynamics of clinical efficacy indicators during 6 months of therapy.Material and methods. …”
Get full text

Dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke receiving beta-blockers by O. A. Osipova, E. V. Gosteva, O. N. Belousova, S. G. Gorelik, N. I. Klyushnikov, Yu. A. Lykov, A. N. Khachaturov, V. V. Bukatov

“…To compare the effect of beta-blocker therapy (bisoprolol and nebivolol) on the dynamics of fibrotic and vascular endothelial dysfunction markers in elderly hypertensive patients after ischemic stroke (IS).Material and methods. …”
Get full text

N-terminal propeptide of type III procollagen for predicting diastolic dysfunction in patients with myocardial infarction and preserved ejection fraction by A. V. Osokina, V. N. Karetnikova, O. M. Polikutina, A. V. Ivanova, O. E. Avramenko, O, V. Gruzdeva, O. L. Barbarash

“…On the first day of MI, 25 (29,1%) patients with signs of diastolic dysfunction (DD) were identified among those with preserved LVEF. …”
Get full text

Sexuality of women aged 60+ with hypertension by Agnieszka Pawełko, Maria Ciechacka, Ewelina Bąk

Get full text

The impact of obesity on sexual functioning among women by Maria Ciechacka, Agnieszka Pawełko, Ewelina Bąk

Get full text

Physiological characteristics of reproductive-age patients with female sexual dysfunction and endometriosis (a comparison of clinical and laboratory parameters in different study g... by O. I. Kryzhanovska, L. M. Semeniuk

“…About two-thirds of women with endometriosis have sexual dysfunction caused by dyspareunia, which negatively affects the quality of life and mental health of a woman. …”
Get full text

Izuchenie vliyaniya sulodeksida na endoteliy-zavisimuyu vazodilatatsiyu mozgovykh sosudov u zhivotnykhso streptozototsin-indutsirovannym sakharnym diabetom by Ivan Nikolaevich Tyurenkov, Andrey Vladislavovich Voronkov, Anna Al'bertovna Slietsans, Evgenia Viktorovna Petrova, Grigoriy Leonidovich Snigur

“…To analyse effects of sulodexide on endothelium-dependent vasodilation (EDVD) of brain vessels in animals with experimental diabetes mellitus. Materials and methods. The study was performed on 45 Wistar male rats (180-219 g b.w.) allocated to 3 equal groups. …”
Get full text

The role of matrix metalloproteinases in left ventricular remodeling in patients with ST-segment elevation myocardial infarction by T. B. Pecherina, O. V. Gruzdeva, O. L. Barbarash

“…Patients with systolic dysfunction (< 55% left ventricular ejection fraction, n = 128) and diastolic dysfunction (E/A < 1, n = 112) had higher concentrations of all indicated markers, yet statistically significant differences were determined only for MMP-3, NT-proBNP, and proANP in patients with systolic dysfunction and for MMP-9 in those with diastolic dysfunction both on the 1st and 12th day after STEMI onset.Conclusion. …”
Get full text

Serum Endocan as a Predictor of Survival and Cardiovascular Events in Patients Without Diabetic Kidney Disease on Chronic Haemodialysis: A Prospective, Observational Study by Mario Šafer, Ivan Feldi, Ines Šahinović, Ivana Tolj, Marko Pirić, Dunja Šojat, Eduard Oštarijaš, Dubravka Mihaljević

“…Endocan, a soluble proteoglycan, emerged as a promising endothelial dysfunction marker and potential major adverse cardiovascular event (MACE) predictor in haemodialysis (HD) patients. …”
Get full text

Endothelium Protective Function of Statins in Men and Women with Coronary Atherosclerosis by M. V. Klimushina, N. G. Gumanova, A. Ju. Gorshkov, N. E. Gavrilova, V. A. Metel'skaja, S. A. Boytsov

Get full text

Predictive value of serum cytokine level in the assessment of complications after liver transplantation by A. Yu. Maksimova, E. N. Bessonova, V. V. Bazarnyy

“…One of the urgent tasks in modern transplantology is the search of biomarkers for predicting and early diagnosis of graft dysfunction.Objective. The study objective was to determine the biomarkers of liver graft dysfunction.Material and methods. …”
Get full text

Neurodynamics in young and middle-aged patients with arterial hypertension by S. A. Smakotina, O. A. Trubnikova, O. L. Barbarash

“…The results obtained verified cognitive dysfunction (CD) presence in young and middle-aged AH patients. …”
Get full text

SDF-1 alleviates osteoarthritis by resolving mitochondrial dysfunction through the activation of the Sirt3/PGC-1α signalling pathway by Yanping Zhao, Dan Lin, Xiaoying Zhu, Jingyao Yan, Yan Liang, Yanli Wang, Tianqi Dai, Zhiyi Zhang, Shuya Wang

“…Results SOD2 and PGC-1α levels were significantly lower in OA chondrocytes and the cartilage of CIOA model mice than in normal chondrocytes, and mitochondrial dysfunction occurred in OA. After treating OA chondrocytes and CIOA model mice with exogenous SDF-1, mitochondrial dysfunction and abnormal biomarkers of OA normalized. …”
Get full text